BioCentury
ARTICLE | Company News

Cadila Pharmaceuticals, Pergamum deal

February 18, 2013 8:00 AM UTC

The companies partnered to develop and commercialize an undisclosed therapeutic peptide to treat infectious diseases. Development of the compound will be conducted at Cadila, which will be responsible...